Semiconductor & Electronics Technology: October 2018

Friday, 26 October 2018

Global qPCR Reagents Market – Application, Development, Size, Growth, Share, Analysis and Forecast 2024

Qualitative polymerase chain reaction (qPCR) reagent is the mixture used in the qPCR technique to quantitate DNA sequence in a sample to synthesis new strands of DNA. It is also known as real-time polymerase chain reaction. The global qPCR reagents market is growing at significant rate due to mounting occurrence of infectious diseases and genetic disorders, technological improvement and speedy progression in geriatric population. The market has witnessed high demand for qPCR core kits over the last few years, due to low prices of core kits.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/qpcr-reagents-market/request-sample

The qPCR reagents market is highly regulated and requires intensive capital for the entry. Moreover, the competition among the players is increasing as the demand for technologically advanced products is increasing.

Geographically, North America is the largest qPCR reagents market as the region is home to large number of industry players. Some of the other factors leading to the growth of the North American market are elevated dispersion of qPCR technologies among end users, mounting public & private grant to magnify the application base of qPCR, continuing product advancements, and constant decrease in the average price of genome sequencing.

Asia-Pacific is observed to witness the fastest growth in the market as the region comprises of largest population. In addition, escalating occurrence of infectious disease and genetic disorder, expanding geriatric population, growing initiatives to enhance awareness associated to gene-based disease treatment, mounting frequencies of criminal cases, growing intensity of global life sciences industries, and mounting private and public support to enlarge innovative digital PCR technologies, are also creating a positive impact on the qPCR reagents industry growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/qpcr-reagents-market

Key players in the industry are investing in the development of innovative and advance quantitative polymerase chain reaction reagents products, which is strengthening their position in the market. Thermo Fisher Scientific, Bio-Rad Laboratories Inc., and Qiagen N.V. together accounted major share of the qPCR reagents market. For instance, In March 2018, Thermo Fisher Scientific Inc., acquired IntegenX Inc., to enhance its product portfolio. IntegenX Inc, is a company which offers a speedy DNA platform for usage in forensics and law implementation applications.

In addition, in April 2018, QIAGEN N.V. launched QIAstat-Dxâ an integrated molecular analysis of common syndromes as tested for in syndromes in infections, oncology and other diseases in Europe. Thermo Fisher Scientific Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Takara Bio Inc., F. Hoffman-La Roche Ltd., Promega Corporation, Qiagen N.V., Agilent Technologies, Inc., Sigma-Aldrich Corporation, and Quanta Biosciences, Inc. are some of the key players offering qPCR reagents products.

About VynZ Research :

VynZ Research is an innovative market research and competitive intelligence company with global competences. We have helped several customers to develop their strategy and make better business decisions by providing actionable intelligence through market research report.

Contact

VynZ Research USA

165 Broadway, 23rd Floor,
New York City, New York – 10006
United States of America
Toll-Free:1-888-253-3960
Email: support@vynzresearch.com
Website: https://www.vynzresearch.com
Connect With us: Linkedin | Twitter | Facebook | Google+

Thursday, 25 October 2018

Global Guidewires Market – Application, Analysis, Size, Trends and Forecast 2024

Guidewires is a flexible wire inserted into the confined space as to guide instrument. It is mainly used in vascular intervention. The global guidewires market is growing at significant rate, due to escalating acceptance of minimally invasive surgery and increasing healthcare expenditure. The market has witnessed high demand for surgical guidewires over the last few years due to mounting regulatory directive executed for the prevention of healthcare related infection and escalating number of surgical treatment.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/guidewires-market/request-sample

Globally, the manufacturing companies are extensively involved in research and development of products in order to cater various medical procedures. Moreover, manufacturing companies have to abide strict regulatory requirements. However, rapid technological advancements have created immense opportunity for the manufacturers to leverage the market potential.

Geographically, North America is the largest guidewires market as in the region there is robust presence of key OEMs. In addition, the huge target patient population base those experiencing minimally invasive surgical procedures, mounting prevalence of lifestyle associated diseases, and escalating acceptance of more sophisticated wires are driving the growth of the North American guidewires market. Moreover, escalating geriatric population, mounting occurrence of cardiovascular diseases, and boosting reimbursement among developed countries are also up surging growth of the North American market.

Asia-Pacific is observed to witness fastest growth in the market. In addition, multiplying number of surgical and diagnostic procedures, boosting healthcare expenditure, escalating geriatric population, mounting prevalence of lifestyle associated diseases and modernization & expansion of healthcare infrastructure are also creating a positive impact on the guidewires industry growth in the region.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/guidewires-market

Key players in the guidewires market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In May 2018, Medtronic announced advanced SynergyTLIF workflow, an integrated fully navigated procedure with less surgical procedures for lumbar spine surgery. Moreover, in February 2017, Medtronic received FDA and CE clearance for DxTerity Diagnostic Angiography Catheter line and transradial-specific products such as TRAcelet compression device, DxTerity TRA, and InTRAkit access kit in its coronary product portfolio.

Medtronic PLC, Boston Scientific, C.R. Bard, Terumo Corporation, Abbott Laboratories, B. Braun, Johnson & Johnson, Stryker Corporation, Olympus Corporation, Angiodynamics, and Cardinal Health are the key players offering guidewires.

About VynZ Research :

Contact

VynZ Research USA

Wednesday, 10 October 2018

Globle Technical News - Pyrogen Testing Market - LAL Tests, Rabbit Tests, and In Vitro Tests, Trends and Forecast to 2024

Pyrogen testing is the compulsory phase in the manufacturing process to eliminate or deactivate probable bacterial contaminants. Its products are used for the treatment and diagnostic purposes. The global pyrogen testing market is growing at a significant rate, due to speedy growth in pharmaceutical and biotechnology industries and mounting number of novel drug launches. Different products contributed to the pyrogen testing market size. The market has witnessed high demand for kits and reagents in the coming years due to mounting implementation of kit-based testing and recurrence purchase of kits and reagents as compared to instruments

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/pyrogen-testing-market/request-sample

Globally, the manufacturing companies trying to enter the pyrogen testing market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier for the entry of new players. This offers an edge to the established players in the industry competition.

Geographically, North America is the largest pyrogen testing market as in the region the investment by government in healthcare and pharmaceutical industry is increasing. Research and development of novel drugs, mounting burden of chronic diseases, and upsurge in a number of biologic products are also up surging growth of the North American pyrogen testing market. For instance, according to GLOBOCAN in the U.S. approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/pyrogen-testing-market

Asia-Pacific is observed to witness fastest growth in the market, due to mounting research and development of novel drugs. In addition, mounting occurrence of chronic diseases, and mounting healthcare expenditure are also creating a positive impact on the pyrogen testing market growth in the region.

Key players in the pyrogen testing market are catering the demand of these devices by investing on technologically advanced products in their product portfolio across the globe. In March 2018, Associates of Cape Cod, Inc., introduced a new, swift endotoxin recognition kit, Pyrosate, an easy-to-use Limulus Amebocyte Lysate (LAL) gel-clot test which enables rapid testing. Associates of Cape Cod, Inc., Merck KGaA, Thermo Fisher Scientific, Inc., GenScript, Charles River Laboratories, Inc., Ellab A/S, Lonza Group, and WUXI Pharmatech (Cayman) Inc. are the key players offering pyrogen testing.

About VynZ Research :

Contact

VynZ Research USA

Global Intraoperative Imaging Market - Neurosurgery, Orthopedic, Analysis and Forecast to 2024

The global intraoperative imaging market is predicted to grow at 6.1% CAGR during the forecast period with the market size reaching USD 2.6 billion by 2024. Different products such as mobile c-arms, intraoperative computed tomography, intraoperative magnetic resonance imaging, and intraoperative ultrasound are majorly contributing to the intraoperative imaging market size. The market has witnessed significant demand for mobile c-arm over the last few years due to the mounting occurrence of cardiovascular diseases, and expanding number of orthopedic surgeries.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/intraoperative-imaging-market/request-sample

Key factors hindering the growth of the intraoperative imaging market are the high cost of the intraoperative imaging device, strict regulatory requirement, and lack of skilled professionals. In addition, risks and complications using intraoperative devices is also having a negative impact on the growth of the intraoperative devices market

Geographically, North America is the largest intraoperative imaging market as the region the demand for the minimally invasive procedure is increasing and well-developed healthcare infrastructure. In addition, the mounting occurrence of chronic diseases and lifestyle associated diseases, and expanding geriatric population are also fueling the growth of the North American intraoperative imaging market. For instance, according to GLOBOCAN in the U.S., approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/intraoperative-imaging-market

Asia-Pacific is observed to witness significant growth in the intraoperative imaging market during the forecast period, as the region comprises of a large population, government initiatives in establishing innovative technologies, and refining healthcare infrastructure. Moreover, intensifying healthcare expenditure, expanding the geriatric population, growing occurrence of orthopedic disorder, demand for refined medical service, and mounting occurrence of chronic diseases and lifestyle associated diseases are also facilitating the significant growth of Asia-Pacific intraoperative imaging industry.

Market players in the intraoperative imaging industry are investing capital to develop technologically advanced systems. In November 2017, Ziehm Imaging strengthens its position in mobile C-arm imaging by the introduction of CMOS line, which completes CMOS portfolio from compact mini C-arms to powerful high-end devices. Medtronic Plc, Ziehm Imaging GmbH, General Electric Company, Koninklijke Philips NV, Toshiba Corporation, Siemens AG, Brainlab AG, and Shimadzu Corporation are some of the key players offering solutions for intraoperative imaging.

About VynZ Research :

Contact

VynZ Research USA

Monday, 8 October 2018

Global Image-Guided Surgery Devices Market - X-Ray Fluoroscopy, Development, Trends and Forecast to 2024

The global image-guided surgery devices market is predicted to grow at 7.1% CAGR during the forecast period with the market size reaching USD 6.3 billion by 2024. Image-guided surgery is also known as navigation surgery, it visually correlates intraoperative anatomy with preoperative CT scan. Image-guided surgery devices are used for guiding surgeons during the surgery. It enhances accuracy during the surgery, decreases procedure time, reduces complexity, and insignificant surgical scar.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/image-guided-surgery-devices-market/request-sample

Key factors hindering the growth of the image-guided surgery devices market are the high cost of imaging technique, and strict regulatory requirement. In addition, the lack of awareness is also having a negative impact on the growth of the image-guided surgery devices market.

Geographically, North America is the largest image-guided surgery devices market as the region is home to a large number of industry players and has a high frequency of acceptance of novel technologies. In addition, expanding geriatric population, escalating demand of non-invasive surgery, obtainability of skilled professionals, mounting healthcare awareness, intensifying demand of minimally invasive surgery, the mounting occurrence of neurological disorder, and escalating healthcare expenditure are also fueling the growth of the North American image-guided surgery devices market.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/image-guided-surgery-devices-market

Asia-Pacific is observed to witness significant growth in the image-guided surgery devices market during the forecast period, as the region comprises of a large population, and refining healthcare infrastructure. Moreover, expanding the geriatric population, intensifying demand for minimally invasive surgery, mounting healthcare awareness, and speedily increasing medical tourism are also facilitating the significant growth of Asia-Pacific image-guided surgery devices industry.

Market players in the image-guided surgery devices industry are investing capital to develop technologically advanced systems. In June 2018, Royal Philips acquired EPD Solutions, to improve its product portfolio of image-guided procedures for cardiac arrhythmias. Siemens AG, Koninklijke Philips N.V, Medtronic Plc, Stryker Corporation, Hitachi, Ltd., Varian Medical Systems, Inc., Smith & Nephew plc, KARL STORZ GmbH & Co. KG., Zimmer Holdings, Inc., and General Electric are some of the key players offering solutions for image-guided surgery devices.

About VynZ Research :

Contact

VynZ Research USA

Global E-Clinical Solutions Market - On-Demand/ Web-Based, On-Premise, and Cloud-Based, Growth Factor, Trends and Forecast to 2024

The global e-clinical solutions market is predicted to grow at 11.9% CAGR during the forecast period with the market size reaching USD 10.4 billion by 2024. Different types of solutions such as electronic data capture (EDC) and clinical data management system (CDMS), clinical trial management system (CTMS), clinical analytics platforms, and randomization and trial supply management are majorly contributing to the e-clinical solutions market size. The market has witnessed significant demand for electronic data capture and clinical data management system over the last few years due to mounting demand for improved data standardization.

Download free Report Sample at: https://www.vynzresearch.com/healthcare/e-clinical-solutions-market/request-sample

Key factors hindering the growth of the e-clinical solutions market are the high cost of implementation, the low adoption rate of the software, lack of high-speed broadband facility and long approval time. In addition, the dearth of skilled professionals is also having a negative impact on the growth of the market.

Geographically, North America is the largest e-clinical solutions market as the region is home to a large number of industry players. In addition, mounting demand for improved data standardization and upsurge in spends on research and development by pharmaceutical and biotechnology companies are also fueling the growth of the North American e-clinical solutions market.

Asia-Pacific is observed to witness significant growth in the e-clinical solutions market during the forecast period, as the region comprises of a large population, easy patient recruitment, and the existence of less strict regulatory strategies. Moreover, mounting government sponsoring to strengthen clinical trials, the less operational cost for clinical trials, intensifying healthcare expenditure, increasing outsourcing of clinical trials, and growing number of pharmaceutical companies and CROs are also facilitating the significant growth of Asia-Pacific e-clinical solutions industry.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/e-clinical-solutions-market

Market players in the e-clinical solutions industry are investing capital to develop technologically advanced systems. In February 2018, OmniComm Systems, Inc. acquired Algorics, to enhance its product portfolio in a clinical analytics solution. Oracle Corporation, PAREXEL International Corporation Medidata Solutions, Inc., DATATRAK International, Inc., eClinical Solutions, Inc., Bio-Optronics, Inc., ERT, MaxisIT Inc., and OmniComm Systems, Inc. are some of the key players offering solutions for e-clinical solutions.

About VynZ Research :

Contact

VynZ Research USA

Global Laboratory Information System (LIS) Market - Standalone and Integrated, Web-Based, On-Premise, Analysis and Forecast to 2024

The global laboratory information system market is predicted to grow to USD 3.2 billion by 2024, growing at a CAGR of 8.5% during the forecast period. Different products such as integrated an standalone are majorly contributing to the laboratory information system market size. Laboratory information system (LIS) is a software solution which manages the obtaining, handling, and storage of information created by laboratories. It helps to simplify laboratory processes to decline specimen handling time, enhance turnaround time, and upsurge productivity.

Download Free Report Sample at: https://www.vynzresearch.com/healthcare/laboratory-information-system-market/request-sample

Key factors hindering the growth of the laboratory information system market are the high cost of LIS, interoperability and technical issues. In addition, the dearth of skilled professionals and requirement of specialized laboratory units for chemistry, hematology, and microbiology is also having a negative impact on the growth of the market.

Geographically, North America is the largest laboratory information system market as in the region the occurrence of chronic diseases is increasing, regulatory mandates in the U.S., and mounting personalized medicine initiatives. In addition, mounting initiatives by government and industry players in healthcare IT, expanding need for quality cancer diagnosis, the mounting requirement for the integrated healthcare system, and escalating healthcare spending are also fueling the growth of the North American laboratory information system market.

Expllore Full Report Description at: https://www.vynzresearch.com/healthcare/laboratory-information-system-market

Asia-Pacific is observed to witness significant growth in the laboratory information system market during the forecast period, as the region comprises of a large population, cancer diagnostic initiatives, mounting requirement for the integrated healthcare system, escalating awareness of LIS, and mounting EHR adoption. Moreover, intensifying healthcare expenditure, government schemes to increase healthcare IT, refining healthcare infrastructure, and mounting occurrence of chronic diseases are also facilitating the significant growth of Asia-Pacific laboratory information system industry.

Market players in the laboratory information system industry are investing capital to develop technologically advanced systems. In April 2018, SCC Soft Computer and Australian Red Cross Blood Service have introduced an implementation study to assess SCC’s laboratory and genetics information management systems. Cerner Corporation, SCC Soft Computer, Mckesson Corporation, Compugroup Medical AG, EPIC Systems Corporation, Computer Programs and Systems, Inc., International Business Machines, and Orchard Software Corporation are some of the key players offering solutions for laboratory information system.

About VynZ Research :

Contact

VynZ Research USA

Sunday, 7 October 2018

Global MRI Guided Neuro Ablation Devices Market - MRI Guided RF Ablation System, Dvelopment, Trends and Forecast to 2024

The global MRI guided neuro ablation devices market is predicted to grow at 5.3% CAGR during the forecast period with the market size reaching USD 175.6 million by 2024. Different products such as MRI guided RF ablation system, MRI guided focused ultrasound systems, and MRI guided laser therapy system are majorly contributing to the MRI guided neuro ablation devices market size. The market has witnessed significant demand for MRI guided RF ablation system over the last few years due to mounting awareness of minimally invasive surgery.

Download Free Sample Copy of Research Report: https://www.vynzresearch.com/healthcare/mri-guided-neuro-ablation-devices-market/request-sample

Key factors hindering the growth of the MRI guided neuro ablation devices market are limited awareness among patient about the treatment brain tumor in developing countries, high cost, and a limited workforce. In addition, the dearth of skilled professionals is also having a negative impact on the growth of the market.

Geographically, North America is the largest MRI guided neuro ablation devices market as the region geriatric population is increasing and favorable reimbursements policies. In addition, the mounting occurrence of cancer, escalating healthcare expenditure, changing lifestyle, and escalating awareness of minimally invasive surgery are also fueling the growth of the North American MRI guided neuro ablation devices market. For instance, according to GLOBOCAN in the U.S., approximately 1.6 million new cancer cases were diagnosed and there were 0.6 million cancer deaths in 2012.

Explore Full Report Description at: https://www.vynzresearch.com/healthcare/mri-guided-neuro-ablation-devices-market

Asia-Pacific is observed to witness significant growth in the MRI guided neuro ablation devices market during the forecast period, as the region comprises of a large population and expanding the geriatric population. Moreover, mounting occurrence cancer, refining healthcare infrastructure, mounting awareness of minimally invasive surgery, and escalating healthcare expenditure are also facilitating the significant growth of Asia-Pacific MRI guided neuro ablation devices industry.

Market players in the MRI guided neuro ablation devices industry are investing capital to develop technologically advanced systems. In April 2018, Medtronic Plc launched the Visualase, an MRI-guided laser ablation system in Europe. The system offers advanced MRI-guided laser ablation technology which is used in neurosurgery procedures. Medtronic Plc, Insightec Ltd, Monteris Medical Inc, Boston Scientific Corporation, AngioDynamics Inc, and MRI Intervention Inc. are some of the key players offering solutions for MRI guided neuro ablation devices.

About VynZ Research :

Contact

VynZ Research USA